Avi Z. Naider

Avi Z. Naider discloses dealings in Loxo Oncology, Inc. to SEC (Form 4). Over a trading history stretching from 13 December 2018 to 15 February 2019, the count stands at 3 filings.

No open-market sale appears; the market trades are 1 purchase worth €89k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

Most recently, on 15 February 2019, the filings show a transaction in Loxo Oncology, Inc. The last purchase on record was published on 17 December 2018, which is 2,864 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.